dibenzepin
Sign in to saveAlso known as NOV482
Dibenzepin, sold under the brand name Noveril among others, is a tricyclic antidepressant (TCA) used widely throughout Europe for the treatment of depression. It has similar efficacy and effects relative to other TCAs like imipramine but with fewer side effects.
Key facts
- Drug.legal_status
- Rx-only
- Drug.width
- 190
- Drug.Verifiedfields
- changed
- Drug.verifiedrevid
- 447436237
- Drug.IUPAC_name
- 10-(2-(dimethylamino)ethyl)-5-methyl-5H-dibenzo[b,e][1,4]diazepin-11(10H)-one
- Drug.image
- Dibenzepin Structural Formula V1.svg
- Drug.image_class
- skin-invert-image
- Drug.alt
- Skeletal formula of dibenzepin
- Drug.image2
- Dibenzepin 3D spacefill.png
- Drug.image_class2
- bg-transparent
- Drug.alt2
- Space-filling model of the dibenzepin molecule
- Drug.tradename
- Noveril, Anslopax, Deprex, Ecatril, Neodit, Victoril
- Drug.legal_BR
- C1
- Drug.routes_of_administration
- Oral
- Drug.bioavailability
- 25%
- Drug.protein_bound
- 80%
- Drug.metabolism
- Hepatic
- Drug.elimination_half life
- 5 hours
via Wikipedia infobox
Wikidata facts
- Mass
- 295.168
Show 4 more facts
- Commons category
- Dibenzepin
- chemical formula
- C₁₈H₂₁N₃O
- canonical SMILES
- CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C
- World Health Organisation international non-proprietary name
- dibenzepin
via Wikidata · CC0
~3 min read
Article
10 sectionsContents
- Medical uses
- Overdose
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- History
- Society and culture
- Brand names
- References
- External links
Dibenzepin, sold under the brand name Noveril among others, is a tricyclic antidepressant (TCA) used widely throughout Europe for the treatment of depression. It has similar efficacy and effects relative to other TCAs like imipramine but with fewer side effects.
==Medical uses== Dibenzepin is used mainly in the treatment of major depressive disorder.
Connections
histamine antagonist
Entity
tricyclic antidepressant
Entity
flupentixol
Entity
tetracyclic antidepressant
Entity
adrenergic uptake inhibitors
Entity
eslicarbazepine acetate
Entity
seproxetine
Entity
Japan
Country
France
Country
Italy
Country
Europe
Entity
United Kingdom
Country
Switzerland
Country
Israel
Concept
Portugal
Country
liver
Entity
International Standard Book Number
Entity
urine
Entity
feces
Entity
West Germany
Entity